Performa Ltd (US)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Performa Ltd (US)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$8.08K	–	57
2025 Q3	$8.08K	Buy	400 +100	+33%	+$1.76K	﹤0.01%	29
2025 Q2	$5.03K	Buy	+300	New	+$4.84K	﹤0.01%	37
2024 Q3	–	Sell	-385	Closed	-$6.26K	–	57
2024 Q2	$6.26K	Sell	385 -200	-34%	-$3.08K	﹤0.01%	39
2024 Q1	$8.25K	Hold	585	–	–	﹤0.01%	37
2023 Q4	$6.11K	Hold	585	–	–	﹤0.01%	40
2023 Q3	$5.97K	Hold	585	–	–	﹤0.01%	49
2023 Q2	$4.4K	Hold	585	–	–	﹤0.01%	61
2023 Q1	$5.18K	Hold	585	–	–	﹤0.01%	56
2022 Q4	$5.34K	Hold	585	–	–	﹤0.01%	53
2022 Q3	$5K	Sell	585 -215	-27%	-$1.9K	﹤0.01%	51
2022 Q2	$6K	Buy	800 +50	+7%	+$436	﹤0.01%	38
2022 Q1	$7K	Sell	750 -300	-29%	-$2.5K	﹤0.01%	28
2021 Q4	$8K	Buy	1,050 +650	+163%	+$5.87K	﹤0.01%	32
2021 Q3	$4K	Buy	400 +300	+300%	+$2.81K	﹤0.01%	37
2021 Q2	$1K	Hold	100	–	–	﹤0.01%	47
2021 Q1	$1K	Sell	100 -50	-33%	-$573	﹤0.01%	37
2020 Q4	$1K	Buy	+150	New	+$1.44K	﹤0.01%	36
2020 Q1	–	Sell	-15,000	Closed	-$147K	–	13
2019 Q4	$147K	Sell	15,000 -3,300	-18%	-$29.5K	0.14%	7
2019 Q3	$169K	Hold	18,300	–	–	0.17%	5
2019 Q2	$169K	Buy	+18,300	New	+$221K	0.17%	5

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Performa Ltd (US)'s TEVA Position: Q4 2025 in Review

Performa Ltd (US) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2025, closing a stake of 400 shares — an estimated $8.08K sold.

Performa Ltd (US) first reported a position in TEVA in Q2 2019 and held it in 20 quarters. The position peaked at $169K in Q3 2019. 636 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

Performa Ltd (US) reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2025 after selling out during the quarter.
Performa Ltd (US) sold 400 Teva Pharmaceutical Industries Limited shares in Q4 2025, an estimated $8.08K.
Performa Ltd (US) first reported a position in Teva Pharmaceutical Industries Limited in Q2 2019 and held it in 20 quarters.
Performa Ltd (US)'s Teva Pharmaceutical Industries Limited position peaked at $169K in Q3 2019.
636 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2025.

Based on Performa Ltd (US)'s 13F filing for Q4 2025, filed 10 Feb 2026.